Dr. Kiran Turaga

Biography

Kiran Turaga, MD, MPH, is the Division Chief of Surgical Oncology and Assistant Medical Director for the Clinical Trials Office at Yale Cancer Center. He previously served as Vice Chief of the Section of General Surgery and Surgical Oncology at the University of Chicago, where he directed the Surgical Gastrointestinal Cancer Program. Considered a thought leader in the management of oligometastatic cancer, Dr. Turaga specializes in regional perfusion and hyperthermic intraperitoneal chemotherapy (HIPEC), a technique allowing for high doses of heated chemotherapy to be delivered directly to abdominal organs. His research emphasizes the development of novel diagnostics and therapeutics for oligometastatic cancer, and he is the principal investigator on clinical trials investigating the integration of immunotherapy and liquid biopsy in surgical cancer management. He is also interested in utilizing big data systems to optimize patient care. Dr. Turaga's commitment to addressing the challenges faced by cancer patients is deeply personal, influenced by the loss of family members to the disease. He advocates for innovative technologies in cancer treatment, including laparoscopic and robotic surgeries, to enhance recovery and outcomes for patients.

Research Interests